Cargando…

Expanding the spectrum of “mesenchymal” tumors of the central nervous system

In this review, we summarize the clinical, histopathological, and molecular features of central nervous system (CNS) tumors with BCOR internal tandem duplication, intracranial mesenchymal tumor with FET/CREB fusion, CNS CIC-rearranged sarcomas and primary intracranial sarcoma DICER1-mutant, now incl...

Descripción completa

Detalles Bibliográficos
Autores principales: Pizzimenti, Cristina, Gianno, Francesca, Gessi, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Pacini Editore srl 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763981/
https://www.ncbi.nlm.nih.gov/pubmed/36534424
http://dx.doi.org/10.32074/1591-951X-826
_version_ 1784853177676333056
author Pizzimenti, Cristina
Gianno, Francesca
Gessi, Marco
author_facet Pizzimenti, Cristina
Gianno, Francesca
Gessi, Marco
author_sort Pizzimenti, Cristina
collection PubMed
description In this review, we summarize the clinical, histopathological, and molecular features of central nervous system (CNS) tumors with BCOR internal tandem duplication, intracranial mesenchymal tumor with FET/CREB fusion, CNS CIC-rearranged sarcomas and primary intracranial sarcoma DICER1-mutant, now included in the 2021 WHO classification of CNS tumors. Possible relationships between tumors occurring in the CNS and their systemic counterparts are discussed.
format Online
Article
Text
id pubmed-9763981
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Pacini Editore srl
record_format MEDLINE/PubMed
spelling pubmed-97639812023-01-03 Expanding the spectrum of “mesenchymal” tumors of the central nervous system Pizzimenti, Cristina Gianno, Francesca Gessi, Marco Pathologica Review In this review, we summarize the clinical, histopathological, and molecular features of central nervous system (CNS) tumors with BCOR internal tandem duplication, intracranial mesenchymal tumor with FET/CREB fusion, CNS CIC-rearranged sarcomas and primary intracranial sarcoma DICER1-mutant, now included in the 2021 WHO classification of CNS tumors. Possible relationships between tumors occurring in the CNS and their systemic counterparts are discussed. Pacini Editore srl 2022-12-01 /pmc/articles/PMC9763981/ /pubmed/36534424 http://dx.doi.org/10.32074/1591-951X-826 Text en © 2022 Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access journal distributed in accordance with the CC-BY-NC-ND (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) license: the work can be used by mentioning the author and the license, but only for non-commercial purposes and only in the original version. For further information: https://creativecommons.org/licenses/by-nc-nd/4.0/deed.en
spellingShingle Review
Pizzimenti, Cristina
Gianno, Francesca
Gessi, Marco
Expanding the spectrum of “mesenchymal” tumors of the central nervous system
title Expanding the spectrum of “mesenchymal” tumors of the central nervous system
title_full Expanding the spectrum of “mesenchymal” tumors of the central nervous system
title_fullStr Expanding the spectrum of “mesenchymal” tumors of the central nervous system
title_full_unstemmed Expanding the spectrum of “mesenchymal” tumors of the central nervous system
title_short Expanding the spectrum of “mesenchymal” tumors of the central nervous system
title_sort expanding the spectrum of “mesenchymal” tumors of the central nervous system
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9763981/
https://www.ncbi.nlm.nih.gov/pubmed/36534424
http://dx.doi.org/10.32074/1591-951X-826
work_keys_str_mv AT pizzimenticristina expandingthespectrumofmesenchymaltumorsofthecentralnervoussystem
AT giannofrancesca expandingthespectrumofmesenchymaltumorsofthecentralnervoussystem
AT gessimarco expandingthespectrumofmesenchymaltumorsofthecentralnervoussystem